DYRK2 and neuroblastoma: Regarding nervous system malignancies, Uhl found DYRK2 and DYRK3 upregulation in neuroblastoma (an aggressive tumor affecting the sympathetic system and/or adrenal glands in early childhood) patients with poor prognoses (Uhl et al., 2018).